The Direct and Indirect Costs Associated With Overactive Bladder Within a Commercially-Insured Population in the United States

OBJECTIVE:To quantify the burden associated with overactive bladder (OAB) within a commercially-insured United States (US) population. METHODS:Adults with OAB identified from the MarketScan databases (2008 to 2013) were propensity score matched 1:1 to non-OAB controls. Per-patient-per-month (PPPM) direct healthcare costs, and indirect costs attributable to workplace absence and short-term disability (STD), were estimated. RESULTS:Adjusted PPPM healthcare costs were higher for OAB patients than matched controls for both direct costs ($3003 vs $1123; P